Arkolith/Insider Trading/AKLI/Form 4

Temasek Life Sciences Private Ltd

10% OwnerAkili, Inc. (AKLI) · full profile →Form 4 · filed Jul 5, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 2, 2024Tender(U)10.3M——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 2, 2024Tender(U)1.2M——0

Transaction Codes

U
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-081811) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML